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Aim 
Dystonia is a movement disorder characterized by involuntary muscle contractions, 
resulting in abnormalities of posture and movement. Children with dystonia are at 
risk of developing fixed musculoskeletal deformities (FMDs). FMDs cause pain, limit 
function and participation and interfere with care. We aimed to explore factors 
relating to the development of FMD in a large cohort of children with dystonia. 
 
Method 
 
The case notes of all children referred to our Complex Motor Disorder service 
between July 2005 and December 2011 were reviewed. Data from 279 children 
(median age 9 years 10 months, Standard Deviation 4 years 2 months) with motor 
disorders including a prominent dystonic element were analysed. Parametric 
accelerated failure time regression was used to identify the factors related to 
development of contractures. 
 
Results 
 
FMDs were present at referral in more than half (n=163, 58%) of cases. Three 
quarters (n=120, 74%) of children with FMD had deformities around the hip, and 
42% had spinal deformity (n=68). Compared to pure primary dystonia, FMD onset 
was earlier with a diagnosis of secondary or heredodegenerative dystonia, and a 
mixed spastic-dystonic phenotype (all p<0.001). FMD onset was also earlier with 
increasing Gross Motor Function Classification System (GMFCS) level (p<0.001). 
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The effect of aetiological classification was lost when controlling for GMFCS level 
and motor phenotype. 
 
Interpretation 
  
Children with secondary or heredodegenerative dystonia are at greater risk of 
progression to FMD compared to primary dystonia, likely due to more severe 
dystonia within these groups. Children with additional spasticity are at particular risk, 
requiring close monitoring. 
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Dystonia is characterized by  “sustained or intermittent muscle contractions causing 
abnormal, often repetitive, movements, postures, or both”1. Dystonia has most 
commonly been classified on an aetiological basis as “primary”, “primary-plus”, 
“secondary” or “heredodegenerative”2. In primary dystonia, dystonic movements are 
the only abnormality, in the absence of any exogenous cause and with normal 
neuroimaging. In Primary-plus dystonia other abnormal movements are present.3 
Secondary dystonia is a symptomatic disorder, arising due to a disease processes 
affecting the brain, often with additional neurological features. Heredodegenerative 
dystonias are those arising in the context of progressive neurodegeneration. 
Secondary dystonias are more common in childhood4 5. Whilst a move away from 
this terminology has recently been proposed1, it remains a useful way to classify 
dystonias from diverse aetiologies into groupings with common features for 
comparative work. 
 
Dystonia in childhood can interfere with all domains of the International Classification 
of Functioning, Disability and Health (ICF) framework6 7, including impairment, 
activity and participation, with significant implications for future adult life.  
 
In general, hypertonic movement disorders are associated with the development of 
fixed musculoskeletal deformity (FMD). FMDs cause pain, limit function, impair sleep 
and create difficulties with care. Without effective intervention, progression of FMD 
and worsening impairment of function will occur8-10, though the rate of this 
progression varies for each individual.  Cerebral palsy (CP) has been the focus of 
much of the work around FMD development, which has been related to increasing 
impairment of function11 12. Most studies have focused on patients with 
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predominantly spastic motor disorders (the most common impairment in CP), with 
only small numbers of children with dystonic CP included. Large studies of FMD in 
children with dystonia are absent. We aimed to explore which clinical factors were 
related to the development of FMDs in a group of children and young people (CAYP) 
referred to our supra-regional complex motor disorder service (CMDS). 
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Method 
 
All CAYP assessed by our CMDS between June 2005 and December 2012 were 
considered for inclusion in this study. Our service offers a supra-regional referral 
service for CAYP with dystonic motor disorders, primarily with view to assessment 
for suitability for ITB/DBS. Demographic/clinical characteristics were extracted from 
patient case notes. Details of musculoskeletal examinations performed by three of 
the authors were reviewed (MK and JL, Paediatric Neurologists with > 10 years of 
experience, and KT, a Clinical Specialist Paediatric Physiotherapist with >10 years of 
experience working with children with complex neurodisability). Clinical features of 
CAYP in this cohort have previously been reported5 7. 
 
A pragmatic definition of FMD was used: Fixed deformity of a limb/joint impairing 
function due to contracture (i.e. permanent tightening of non-bony tissue) and not 
due to active contraction, restricting daily activity/participation and/or impairing the 
delivery of care whether through a direct restriction of movement or secondary to 
pain/discomfort. When present, FMDs were categorized on the basis of body region 
affected into i) hip, ii) spine or iii) peripheral.  Deformity at multiple regions was 
recorded when present. 
 
Details of CAYP diagnosis and aetiological classification were recorded. Motor-
phenotype was classified as i) pure dystonia, ii) mixed dystonia-spasticity, iii) 
dystonia-choreoathetosis, iv) dystonia-myoclonus, v) dystonia with prominent tremor, 
or vi) dystonia-parkinsonism. CAYP deemed to have a purely spastic motor 
phenotype were excluded.  
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The Gross Motor Function Classification System (GMFCS) 13 was used to classify 
motor function. This scale has been validated for children with CP, and so should be 
considered “GMFCS equivalent” as not all children in this study had this diagnosis. 
For 132 patients dystonia severity had also been assessed using the Burke-Fahn-
Marsden Dystonia Rating Scale (BFMDRS)14. Videotaped BFMDRS evaluations 
were scored by 2 clinicians, not blinded to other clinical/demographic details.  
 
Statistical analysis was performed using the R language for Statistical Computing, 
version 2.15.2 (R Foundation for Statistical Computing, Vienna, Austria), and the 
survival package, version 2.36-14 (Terry M. Therneau, Mayo Clinic, Rochester, USA) 
15
. Age of FMD onset was considered to be interval censored between the age of 
onset of dystonia and age of referral to our service for CAYP with FMD at referral 
and right-censored at age of referral for CAYP without FMD at referral, based on the 
assumption of eventual progression to FMD over time 8 9. Parametric accelerated 
failure time models using the log-normal distribution were fitted to identify which 
clinical factors led to an earlier or later onset of FMD. A parametric approach was 
chosen to give greater power to the analysis of the interval-censored observations. 
An accelerated failure time model was used both because the assumptions of a 
proportional hazards model were not met and because accelerated failure time 
models are more robust to model misspecification16 17. The log-normal model was 
chosen because it provided the best fit of 6 models considered. Modelling 
assumptions were checked using diagnostic plots and relevant statistics. Median 
event times, 95% confidence intervals and p-values were calculated. Aetiological 
classification, motor-phenotype, GMFCS level and age of dystonia onset were used 
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as covariates in the models – both in univariate and in multivariate models. Small 
subgroups of less than 20 patients (e.g. patients with Dystonia-Myoclonus, Dystonia-
Choreoathetosis, Dystonia tremor, or Dystonia-Parkinsonism motor-phenotype) were 
merged together to produce sufficiently large groups for statistical modelling. 
 
The study was registered as an audit with Guy’s and St Thomas NHS Trust. Since 
the data were not personally identifiable, consent was neither required nor obtained. 
Data were permanently anonymised and handled according to Caldicott principles 
and the requirements of the Data Protection Act. 
 
 
 
 
 
 
 
Results 
Case notes were available for 294/320 (92%) CAYP referred to our service between 
July 2005 and December 2011, 15 of whom were excluded from further analysis due 
to a purely spastic motor phenotype. In the remaining 279 CAYP (summary and full 
details in Table 1), the majority (72%) had secondary dystonia, with primary dystonia 
(11%), primary-plus dystonia (7%) or heredodegenerative dystonia (10%). Pure 
dystonia was the most prevalent motor phenotype (58%), with mixed dystonia-
spasticity the second most prevalent (28%). Age at referral was similar for all 
aetiological classifications. About two thirds (65%) of CAYP with primary or primary-
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plus dystonias had GMFCS levels I-II, while about three quarters (72%) of patients 
with secondary or heredodegenerative dystonias had GMFCS level V.
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Aetiological 
classification 
Age at Referral 
Median  
(25%-75%) 
Age of Onset 
Median  
(25%-75%) 
Motor Phenotype n % 
Functional 
Level 
(GMFCS)  
n % 
All patients 9.8 0.3 Dystonia            161 58% I 26  9% 
(n=279) (6.6 to 13.0) (0.1 to 1.4) Mixed Dystonia Spasticity 79  28% II 26  9% 
  
    Dystonia-Myoclonus 18  6% III 14  5% 
  
    Dystonia Choreoathetosis 16  6% IV 40  14% 
  
    Dystonia Tremor 3  1% V 173  62% 
  
    Dystonia Parkinsonism  2  1%      
Primary 11.9 1.5 Dystonia            30  100% I 8  27% 
(n=30, 10.8%) (8.2 to 14.9) (0.2 to 6.9) Mixed Dystonia Spasticity 0  0% II 11  37% 
  
    Dystonia-Myoclonus 0 0% III 4  13% 
  
    Dystonia Choreoathetosis 0 0% IV 2  7% 
  
    Dystonia Tremor 0 0% V 5  17% 
  
    Dystonia Parkinsonism  0 0%      
Primary-Plus 9.8 3 Dystonia 0  0% I 10  53% 
(n=19, 6.8%) (6.5 to 12.6) (1.0 to 6.0) Mixed Dystonia Spasticity 2  11% II 3  16% 
  
    Dystonia-Myoclonus 14  74% III 1  5% 
  
    Dystonia Choreoathetosis 1  5% IV 3  16% 
  
    Dystonia Tremor 0  0% V 2  11% 
  
    Dystonia Parkinsonism 2  11%      
Secondary 9.5 0.2 Dystonia 111  55% I 7  3% 
(n=201, 72.0%) (6.3 to 12.5) (0.1 to 0.5) Mixed Dystonia Spasticity 73  36% II 10  5% 
  
    Dystonia-Myoclonus 3  1% III 9  4% 
  
    Dystonia Choreoathetosis 13  6% IV 31  15% 
  
    Dystonia Tremor 1  0% V 144  72% 
  
    Dystonia Parkinsonism 0  0%      
Heredodegenerative 9.9 2.2 Dystonia 20  69% I 1  3% 
(n=29, 10.4%) (6.8 to 13.0) (0.8 to 4.0) Mixed Dystonia Spasticity 4  14% II 2  7% 
  
    Dystonia-Myoclonus 1  3% III 0  0% 
  
    Dystonia Choreoathetosis 2  7% IV 4  14% 
  
    Dystonia Tremor 2  7% V 22  76% 
  
    Dystonia Parkinsonism 0  0%   
 
  
 
Table 1. Demographic and clinical classification of 279 children with dystonia by aetiological classification. Percentages in the first column are out of all 
patients while percentages on the right are out of the subgroup shown in the first column. Because numbers are rounded the percentages may not sum up to 
100%.
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FMDs were present at referral in 163 (58%) cases (full details in Table 2). Amongst 
CAYP with FMD, deformity around the hip was most common (74%), followed by 
spinal deformity (42%). FMD was commonest in children with secondary or 
heredodegenerative dystonias compared to other diagnoses, mixed dystonia-
spasticity compared to other motor phenotypes, and GMFCS level V compared to 
lower levels (Pearson's chi-squared tests for independence with small groups 
merged as in Fig. 1 all p<0.001).  
 
BFMDRS motor scores were available for 132 (47%) CAYP (24 primary dystonia, 9 
primary-plus dystonia, 83 secondary dystonia and 16 heredodegenerative dystonia). 
Higher BFMDRS scores were seen in the secondary and heredodegenerative 
groups (median 100 and 86 respectively) compared to primary and primary-plus 
groups (median 59 and 30 respectively, Kruskal-Wallis rank sum test p<0.001). The 
proportion of CAYP with FMD was lower in those for whom BFMDRS scores were 
available (FMD in 67/132, 51%), compared to those for whom BFMDRS scores were 
not available (FMD in 96/147, 65%, Pearson's chi-squared test for independence 
P=0.014). 
 
Parametric accelerated failure time models were fitted by including one of 
aetiological classification, motor phenotype or GMFCS level as explanatory variable 
(Figure 1). Because they exhibited a similar time to FMD onset and individual groups 
were too small to model, the following groups were merged: the primary and primary-
plus groups for aetiological classification, and the 1-2 and 3-4 groups for GMFCS, 
respectively. Also, because they were too small to model, the dystonia-myoclonus, 
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dystonia-choreoathetosis, dystonia tremor, and dystonia-parkinsonism motor 
phenotypes were merged into one group.  
 
 
    
Number 
of 
patients 
Overall 
Deformity Hips Spine Shoulder 
Peripheral 
Contractures 
All patients 
  279 58% 43% 24% 3% 35% 
Aetiological 
Classification 
  
  
Primary 30 23% 13% 3% 0% 20% 
Primary-Plus 19 5% 5% 0% 0% 0% 
Secondary 201 67% 50% 28% 3% 38% 
  Heredodegenerative 29 69% 52% 38% 3% 48% 
Motor 
Phenotype 
  
Pure Dystonia 161 54% 35% 21% 2% 34% 
Mixed Dystonia-
Spasticity 79 86% 75% 38% 4% 49% 
  
Dystonia-
Choreoathetosis 16 38% 25% 25% 0% 12% 
  Dystonia-Myoclonus 18 0% 0% 0% 0% 0% 
  Dystonia Tremor 3 33% 0% 0% 0% 33% 
  
Dystonia 
Parkinsonism 2 50% 50% 0% 0% 0% 
GMFCS 
Level I-II 52 12% 6% 2% 0% 8% 
  Level III-IV 54 41% 22% 7% 0% 30% 
  Level V 173 78% 61% 36% 4% 45% 
 
 
Table 2. Incidence of fixed musculoskeletal deformities in different body regions by aetiological 
classification, motor phenotype, and GMFCS level. The first column shows the absolute number of 
patients in each subgroup while the other columns show the percentage of these patients who have 
FMD either overall or in that specific body region. The shading of the cells is proportional to percent of 
all patients in the first column and percent of patients in that subgroup in all other columns. 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
13 
 
Estimated onset of FMD occurred much earlier in both secondary (estimated median 
age 6 years, p<0.001) and heredodegenerative (estimated median age 7 years, 
p<0.001) groups than in the merged primary and primary-plus dystonia group 
(estimated median age >21 years). Median age at FMD onset decreased 
significantly with increasing GMFCS level (p<0.001): the estimated median age for 
levels 1-2 was >21 years, 10 years for levels 3-4, and only 5 years for level 5. 
Compared to CAYP with pure dystonia, with an estimated median age of 9 years at 
FMD onset, FMD onset occurs significantly earlier, at 4, for patients with mixed 
dystonia-spasticity (p<0.001). The other motor phenotypes generally show later 
onset of FMD, but are too heterogeneous to make a definitive statement. Full details 
including confidence intervals are provided in Table 3. 
 
The GMFCS level gave the most discrimination in age of FMD onset, motor 
phenotype is the second most useful predictor. After allowing for the GMFCS level in 
the model, the inclusion of either motor phenotype or aetiological classification 
provided some additional information (-test for nested models p=0.026 and 
p=0.045, respectively). The direction of all effects remains the same in the models 
with two variables compared to the models with just one variable. A model with both 
GMFCS level and motor phenotype is not significantly improved by adding the 
aetiological classification (-test for nested models). 
 
The BFMDRS motor score (132 patients) was significantly associated with age of 
FMD onset (p<0.001) with higher values corresponding to an earlier FMD onset (c.f. 
Table 3). When BFMDRS was included in the model, GMFCS level was the only 
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other explanatory variable attaining significance (-test for nested models P<0.001), 
despite the fact that both are strongly correlated (Spearman correlation of 0.76). 
 
  
Median age at 
overall FMD onset 
[95% CI] 
Median age at 
hips onset 
[95% CI]  
Median age at 
peripheries onset 
[95% CI]  
All patients 
(no explanatory variables) 
7.8 
[6.6 to 9.0] 
11.7 
[9.5 to 14] 
14.4 
[11.5 to 17.3] 
Aetiological 
Classification 
Primary(-Plus) >21 [15.5 to >21] 
>21 
[16.0 to >21] 
>21 
[16.0 to >21] 
Secondary 6 [5 to 7.1] 
9.1 
[7.4 to 10.9] 
12.1 
[9.8 to 14.4] 
  Heredodegenerative 7.4 [4.4 to 10.4] 
10.3 
[5.2 to 15.3] 
11.2 
[6.3 to 16.1] 
Motor 
Phenotype 
Pure Dystonia 8.6 [7 to 10.3] 
14.4 
[10.8 to 18] 
14.2 
[10.9 to 17.5] 
Mixed Dystonia-
Spasticity 
4 
[2.8 to 5.3] 
5.1 
[3.5 to 6.8] 
10 
[7.2 to 12.7] 
  (Other) 20.9 [11 to >21] 
>21 
[12.2 to >21] 
>21 
[12.8 to >21] 
GMFCS Level I-II >21 [18.8 to >21] 
>21 
[20.5 to >21] 
>21 
[20.1 to >21] 
  Level III-IV 9.9 [7.3 to 12.5] 
16.3 
[10 to >21] 
13.2 
[8.9 to 17.4] 
  Level V 5.1 [4.2 to 5.9] 
7.1 
[5.8 to 8.3] 
10.2 
[8.5 to 11.9] 
BFMDRS 40 18.3 [12.7 to >21] 
>21 
[12.8 to >21] 
>21 
[14.5 to >21] 
  80 9.8 [8.3 to 11.3] 
14.5 
[10.4 to 18.6] 
13.6 
[11.1 to 16.2] 
 
Table 3. Median age at onset of fixed musculoskeletal deformities in different body regions as 
estimated by univariate accelerated failure time models. The 95% confidence intervals refer to the 
median and do not represent the expected ages for 95% of the population. Note the key limitation that 
this model assumes that FMD in any given body region will eventually occur. To avoid extrapolating, 
estimates greater than 21 years are not given. Results for other body regions are not shown, as the 
sample size was insufficient to give useful estimates. 
 
Considering the different body regions, similar relationships were seen with earlier 
onset of FMD with increasing GMFCS level (Table 3). For hip FMD, an earlier onset 
of significant functional deformity was seen with a mixed dystonic-spastic motor 
phenotype compared to a pure dystonic phenotype and with secondary or 
heredodegenerative aetiological classification compared to primary or primary-plus 
classification (Table 3). After accounting for GMFCS level in the model, motor 
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phenotype was the only variable that provided additional information (-test for 
nested models p<0.001). 
 
Discussion 
 
Our current study explored factors relating to age of FMD onset in childhood 
dystonia by evaluating FMD status at the time of referral to our service. FMD onset 
was earlier for children with secondary/heredodegenerative conditions compared to 
primary dystonia (likely due to the more severe dystonia), and mixed dystonia-
spasticity compared to pure dystonia.  
 
FMD arising in CAYP with hypertonicity has been best studied in CP, which has an 
incidence in the developed world of 1 to 3 per 1000 live births18. Studies describing 
contractures in patients with CP have often not distinguished clearly between spastic 
and dystonic motor phenotypes, and when this distinction is made children with 
dystonic motor phenotypes represent only a small minority of the overall cohort. This 
issue is further complicated when one considers that these phenotypes are often 
coincident19 20.  
 
FMD involving the hips was seen most commonly in our cohort (74% of CAYP with 
FMD). Estimates of the prevalence of hip dislocation in CP vary from 1.5 to 75%, 
correlating with the severity of motor impairment21. Hip flexion contractures are 
amongst the most common musculoskeletal deformities seen in CP22 and increasing 
impairment of function has been described with increasing severity of joint 
restriction23. In our cohort, after accounting for the effect of GMFCS level, an earlier 
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onset of FMD with hip deformity was seen in CAYP with a mixed dystonic-spastic 
phenotype compared to a pure dystonia, suggesting this group require closer hip 
surveillance. Similarly, scoliosis has been reported in 15-80% of patients with CP, 
risk appearing to increase with the extent of body involvement and severity of motor 
impairment24. In our cohort an earlier onset of spinal deformity was estimated with 
increasing GMFCS level though age of onset but not motor phenotype. 
 
In our study, the effect of aetiological classification on estimated age at FMD onset 
became insignificant once either motor phenotype or motor severity were included in 
the model.  CAYP with secondary and heredodegenerative groups had more severe 
motor disorders, with higher GMFCS level.  This is may be a result of a referral bias, 
due the perceived efficacy of interventions such as DBS in the primary dystonia 
group. As the efficacy of interventions such as DBS and ITB for secondary dystonia 
is less well established, referral for evaluation may tend to be limited to more 
severely affected patients within these groups.  
 
Whilst a great emphasis has been placed upon the role of physiotherapy and other 
such interventions, there is little evidence to support stretch alone in the prevention 
of contracture in children with hypertonia25. Other early interventions to treat 
spasticity (including ITB) have been suggested to reduce the need for subsequent 
orthopaedic surgery to correct contractures/deformities10 26. Whilst this may relate to 
a slowing of progression to FMD, it is also possible that this is due to decreased 
pain/discomfort associated with established FMD following intervention. The efficacy 
of such interventions as a preventative measures in dystonia is less clear. 
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BFMDRS motor scores were available for only 47% of the cohort. In our clinical 
practice BFMDRS assessments are limited to CAYP for whom an objective measure 
of dystonia is required prior to an intervention, e.g. new medication, DBS/ITB etc. 
The proportion of CAYP with FMD amongst the group for whom BFMDRS motor 
scores were available was significantly lower, potentially limiting applicability of 
findings in this subgroup to the cohort as a whole. Parametric accelerated failure 
time models indicated that both BFMDRS and GMFCS were highly informative for 
predicting the age of FMD onset. Future work is needed to determine whether 
interventions producing changes in BFMDRS scores without changing the GMFCS 
classification for CAYP slow the rate of progression to FMD. 
 
A number of limitations to our study must be acknowledged. Data was collected from 
a convenience sample referred to our supra-regional service, likely to represent the 
more severe end of childhood dystonia. Data was collected retrospectively, with the 
attendant problems of such studies. A pragmatic definition of musculoskeletal 
deformity was used. Whilst we believe this definition is appropriate in focusing 
attention upon deformity adversely affecting the lives of CAYP, it limits direct 
comparisons with other studies. Motor phenotyping was categorical, and, 
consequently, reductive. CAYP with co-incident spasticity often exhibited elements of 
choreoathetosis. Additionally, CAYP, particularly those with CP, with minimal 
choreaothetosis, with a predominantly dystonic movement phenotype where 
categorised as “Dystonia”. Tools have recently been developed which enable the 
separate quantification of dystonia and choreoathetosis in CAYP27. This Dyskinesia 
Impairment Scale (DIS) requires a specifically protocolled video recording to apply, 
and cannot be applied retrospectively. BFMDRS scores were not available for a 
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significant proportion of our cohort. We have captured data at the point of 
assessment by our service. A variable period of time may have passed between the 
development of FMD and the point of assessment. Prospective studies would be 
required to better define the precise timing of the establishment of deformity, though, 
again, defining the point at which restricted range of movement constitutes fixed 
deformity is problematic. We have assumed that, without intervention, progression to 
FMD will eventually occur for all patients and only the rate of this progression varies 
for each individual. The BFMDRS score is known to have limitations when applied to 
secondary dystonias28.  As noted in the methods session, the GMFCS has been 
validated in children with CP, but not in children with other causes of dystonia. In 
other conditions, motor function may not be stable over time (particularly in the 
heredodegenerative group), and could potentially decline rapidly in a short time. We 
would recommend the term “GMFCS equivalent” as a caveat in this patient 
population, to acknowledge this limitation. 
 
The most important limitation, as discussed above, is the referral bias to our centre. 
 
In conclusion, we explored the prevalence of FMD in a large cohort of CAYP with 
dystonic motor disorders referred to our service. A high prevalence of FMD was 
found, particularly around the hip. Earlier FMD onset was seen amongst CAYP with 
secondary and heredodegenerative dystonias, likely due to more severe motor 
impairment, and those with a mixed dystonic-spastic phenotype. These findings are 
comparable to findings in children with spastic CP and support the close monitoring 
of all CAYP with dystonia for contracture development. Given the potential of FMD to 
limit the benefits of interventions to manage childhood dystonia, we would 
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recommend that for children with dystonia (particularly the more severe cases as 
determined by either GMFCS or scales such as the BFMDRS), early referral for 
specialist assessment should be considered. 
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Figure Legends 
 
Figure 1. Parametric accelerated failure time models for age of FMD onset with one 
explanatory variable each. Shown are the median curve for each subgroup (thick 
line) together with 95% confidence intervals (shaded area bordered by dashed lines). 
Left: aetiological classification, centre: motor phenotype, right: GMFCS levels. 
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Highlights: 
1. Fixed Musculoskeletal Deformity (FMD) are common in children with 
dystonia at the time of referral 
2. Progression to FMD is faster with worsening GMFCS level 
3. Progression to FMD is faster in children with both dystonia and 
spasticity 
